For decades, Medical Technology (Med-Tech) companies have embarked in Process Improvement initiatives to enhance product quality while reducing costs. So why are most companies Chasing Defects instead of Improving Processes?
Answers to this complex question are provided in a new research study released by Axendia, Inc.
For this major research Axendia surveyed 239 Medical Technology Industry practitioners from 96 different companies across 22 countries.
While Process Improvement is described by many Med-Tech Executives as an imperative to survival, the benefits of these initiatives have eluded most companies in this sector. The data clearly shows that the majority of Med-Tech companies are still Chasing Defects.
Key findings, analysis and recommendations from this research are available in a series of four white papers and accompanying video briefings under the umbrella: “Is Med-Tech Improving Processes or Chasing Defects.”
Each white paper addresses one of the following themes:
- The Many Sides of Process Improvement
- Chasing Defects
- The Commitment Gap
- So Many Systems, So Little Improvement
To request a copy of these white papers, please visit the research home page
For additional information or to schedule an interview or briefing with the study’s lead researchers, please contact Lisa George via email at lgeorge@axendia.com or by phone at +1 (267) 392-2009
Methodology:
Axendia surveyed 239 Medical Technology Industry practitioners from 96 different companies across 22 countries. Percentages reported are based on those that responded to each individual question in the online survey. The research was also guided by insight from Industry Executives.
This study was sponsored by Camstar Systems Inc. (www.camstar.com), The company supported this research to increase the understanding of processes improvement initiatives across the Medical Technology Industry.
Axendia retained full editorial control during the execution, analysis, and compilation of this report.